Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer

BACKGROUND: Currently, the standard treatment for locally advanced cervical cancer is concurrent chemoradiation (CCRT). Forty percent of patients present with disease recurrence. This study aims to investigate the feasibility, safety and efficacy of neoadjuvant chemotherapy (NACT) with weekly cispla...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Li, Ya, Wang, Huafeng, Shen, Lifei, Wang, Qun, Shao, Siqi, Shen, Yuhong, Xu, Haoping, Liu, Hua, Cai, Rong, Feng, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840535/
https://www.ncbi.nlm.nih.gov/pubmed/36641433
http://dx.doi.org/10.1186/s12885-023-10517-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840535/
https://www.ncbi.nlm.nih.gov/pubmed/36641433
http://dx.doi.org/10.1186/s12885-023-10517-x

Ejemplares similares